111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.02%
Negative revenue growth while CX stands at 13.06%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.02%
Negative gross profit growth while CX is at 23.58%. Joel Greenblatt would examine cost competitiveness or demand decline.
141.83%
EBIT growth above 1.5x CX's 89.85%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
141.83%
Operating income growth above 1.5x CX's 70.77%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-4.55%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.97%
10Y revenue/share CAGR 1.25-1.5x CX's 9.37%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
13.97%
5Y revenue/share CAGR under 50% of CX's 58.59%. Michael Burry would suspect a significant competitive gap or product weakness.
-14.20%
Negative 3Y CAGR while CX stands at 1.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.50%
Negative 3Y CAGR while CX is 19.86%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.